Publication | Closed Access

Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility

InfertilityRandomized Clinical TrialFertilityReproductive HealthGynecologyHuman Menopausal GonadotropinRecombinant Follicle-stimulating HormonePublic HealthEndocrinologyMedicineOvarian HormoneWomen's HealthHuman Reproduction